Comprehensive treatment for the peritoneal metastasis from gastric cancer

doi:10.5412/wjsp.v5.i2.187

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14060)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-13) series, Tables (1-6) series.

Item

Count

PDF

595

WORD

483

HTML

6600

Figures (1-13)

462

Tables (1-6)

237

Sum=8377

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

981

Download

2395

Sum=3376

Publishing Process of This Article

Item

Count

Browse

990

Download

1317

Sum=2307

Jul 28, 2015 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Surgical Procedures

ISSN

2219-2832

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Surg Proced. Jul 28, 2015; 5(2): 187-197
Published online Jul 28, 2015. doi: 10.5412/wjsp.v5.i2.187

Table 3 Histoloogic effects of primary tumor and peritoneal carcinomatosis in 41 patients after bidirectional intraperitoneal and systemic induction chemotherapy

	EF-0	EF-1	EF-2	EF-3	Total
Primary tumors	3 (12%)	15 (58%)	7 (27%)	1 (4%)	26 (100%)
Peritoneal metastasis	7 (17%)	18 (44%)	7 (17%)	9 (22%)	41 (100%)

EF-0: No histological change or histologic change is found in less than one-third of the tumor tissue; EF-1: Degeneration of cancer cells is detected in the tumor tissue ranging from one-third to less than two thirds; EF-2: The degeneration of cancer cells is found in more than two-thirds of the tumor tissue; EF-3: Complete disappearance of cancer cells.

Citation: Yonemura Y, Canbay E, Endou Y, Ishibashi H, Mizumoto A, Li Y, Liu Y, Takeshita K, Ichinose M, Takao N, Saitou T, Noguchi K, Hirano M, Glehen O, Brűcher B, Sugarbaker PH. Comprehensive treatment for the peritoneal metastasis from gastric cancer. World J Surg Proced 2015; 5(2): 187-197
URL: https://www.wjgnet.com/2219-2832/full/v5/i2/187.htm
DOI: https://dx.doi.org/10.5412/wjsp.v5.i2.187